School of Public Health, Guangxi Medical University, Nanning 530021, People's Republic of China; Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning 530021, People's Republic of China.
School of Humanities and Social Sciences, Guangxi Medical University, Nanning 530021, People's Republic of China.
Gene. 2019 Dec 15;720:144103. doi: 10.1016/j.gene.2019.144103. Epub 2019 Sep 3.
Clear cell renal cell carcinoma (ccRCC) is a highly invasive urological malignant tumor that results in shorter patient survival. At present, the mechanism of ccRCC metastasis is not clear. We explored the possible mechanisms of ccRCC metastasis by analyzing the transcriptome of ccRCC patients from the Cancer Genome Atlas (TCGA) database. Comparing the differences in transcriptome in patients with and without metastasis, we found 323 differential genes (|log2FoldChange| > 1 and P < 0.001). KEGG and GO enrichment analyses of differentially expressed genes (DEGs) suggest that the transfer mechanism of ccRCC may be related to complement and coagulation cascades and cholesterol metabolism. To explore the key genes affecting tumor metastasis, we analyzed the association of these genes with patient survival time and found that 16 genes were significantly associated (P < 0.05). We compared the differences in expression of these 16 genes between ccRCC patients and the normal population, and the results showed that TF and B4GALNT1 were overexpressed in patients. Co-expression gene analysis indicated that TF may participate in the metastasis of cancer through the complement system and mucopolysaccharide biosynthesis. B4GALNT1 may affect metastasis through focal adhesion, calcium signaling pathways, and Hippo signaling pathways. Our studies suggest that the complement system and the coagulation cascade, cholesterol metabolism, calcium pathway and iron transport may be associated in the mechanism of metastasis. TF and B4GALNT1 may be the key genes for metastasis, and they may be potential diagnostic markers and therapeutic targets for ccRCC.
透明细胞肾细胞癌(ccRCC)是一种高度侵袭性的泌尿系统恶性肿瘤,导致患者生存时间缩短。目前,ccRCC 转移的机制尚不清楚。我们通过分析癌症基因组图谱(TCGA)数据库中 ccRCC 患者的转录组,探讨了 ccRCC 转移的可能机制。比较有和无转移患者的转录组差异,我们发现了 323 个差异基因(|log2FoldChange|>1,P<0.001)。差异表达基因(DEGs)的 KEGG 和 GO 富集分析表明,ccRCC 的转移机制可能与补体和凝血级联以及胆固醇代谢有关。为了探讨影响肿瘤转移的关键基因,我们分析了这些基因与患者生存时间的相关性,发现其中 16 个基因与患者的生存时间显著相关(P<0.05)。我们比较了这些 16 个基因在 ccRCC 患者和正常人群中的表达差异,结果表明 TF 和 B4GALNT1 在患者中表达上调。共表达基因分析表明,TF 可能通过补体系统和黏多糖生物合成参与癌症的转移。B4GALNT1 可能通过黏附斑、钙信号通路和 Hippo 信号通路影响转移。我们的研究表明,补体系统和凝血级联、胆固醇代谢、钙通路和铁转运可能与转移机制有关。TF 和 B4GALNT1 可能是转移的关键基因,它们可能是 ccRCC 的潜在诊断标志物和治疗靶点。